These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37479616)

  • 1. Pneumococcal carriage, serotype distribution, and antimicrobial susceptibility in Papua New Guinean children vaccinated with PCV10 or PCV13 in a head-to-head trial.
    Orami T; Aho C; Ford RL; Pomat WS; Greenhill A; Kirkham LA; Masiria G; Nivio B; Britton KJ; Jacoby P; Richmond PC; van den Biggelaar AHJ; Lehmann D
    Vaccine; 2023 Aug; 41(37):5392-5399. PubMed ID: 37479616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium.
    Wouters I; Desmet S; Van Heirstraeten L; Blaizot S; Verhaegen J; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2019 Feb; 37(8):1080-1086. PubMed ID: 30665775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants.
    Pomat WS; van den Biggelaar AHJ; Wana S; Francis JP; Solomon V; Greenhill AR; Ford R; Orami T; Passey M; Jacoby P; Kirkham LA; Lehmann D; Richmond PC;
    Clin Infect Dis; 2019 Apr; 68(9):1472-1481. PubMed ID: 30184183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018.
    Wouters I; Desmet S; Van Heirstraeten L; Herzog SA; Beutels P; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
    Euro Surveill; 2020 Feb; 25(5):. PubMed ID: 32046817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.
    Hadjipanayis A; Efstathiou E; Alexandrou M; Panayiotou L; Zachariadou C; Petrou P; Papaevangelou V
    PLoS One; 2016; 11(10):e0163269. PubMed ID: 27706247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants.
    Britton KJ; Pickering JL; Pomat WS; de Gier C; Nation ML; Pell CL; Granland CM; Solomon V; Ford RL; Greenhill A; Hinds J; Moore HC; Richmond PC; Blyth CC; Lehmann D; Satzke C; Kirkham LS;
    Vaccine; 2021 Sep; 39(38):5401-5409. PubMed ID: 34384633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia.
    Sime WT; Aseffa A; Woldeamanuel Y; Brovall S; Morfeldt E; Henriques-Normark B
    BMC Infect Dis; 2019 May; 19(1):409. PubMed ID: 31077141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review.
    Tin Tin Htar M; van Den Biggelaar AHJ; Sings H; Ferreira G; Moffatt M; Hall-Murray C; Verstraeten T; Gessner BD; Schmitt HJ; Jodar L
    Expert Rev Vaccines; 2019 Oct; 18(10):1069-1089. PubMed ID: 31585049
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
    Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal carriage and changes in serotype distribution post- PCV13 introduction in children in Matiari, Pakistan.
    Iqbal I; Shahid S; Kanwar S; Kabir F; Umrani F; Ahmed S; Khan W; Qazi MF; Aziz F; Muneer S; Kalam A; Hotwani A; Mehmood J; Qureshi AK; Hasan Z; Shakoor S; Mirza S; McGee L; Lo SW; Kumar N; Azam I; Bentley SD; Jehan F; Nisar MI
    Vaccine; 2024 Oct; 42(23):126238. PubMed ID: 39168078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease.
    Desmet S; Wouters I; Heirstraeten LV; Beutels P; Van Damme P; Malhotra-Kumar S; Maes P; Verhaegen J; Peetermans WE; Lagrou K; Theeten H
    Vaccine; 2021 Jan; 39(2):372-379. PubMed ID: 33308889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
    Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
    Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
    Milucky J; Carvalho MG; Rouphael N; Bennett NM; Talbot HK; Harrison LH; Farley MM; Walston J; Pimenta F; Lessa FC;
    Vaccine; 2019 Feb; 37(8):1094-1100. PubMed ID: 30685247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in Lima, Peru.
    Gonzales BE; Mercado EH; Castillo-Tokumori F; Montero AE; Luna-Muschi A; Marcelo-Ragas M; Campos F; Chaparro E; Del Águila O; Castillo ME; Saenz A; Reyes I; Hernandez R; Ochoa TJ
    Vaccine; 2023 Jun; 41(28):4106-4113. PubMed ID: 37270366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life.
    Rahman T; de Gier C; Orami T; Seppanen EJ; Granland CM; Francis JP; Michael A; Yoannes M; Corscadden KJ; Ford RL; Martinovich KM; Jacoby P; van den Biggelaar AHJ; Lehmann D; Richmond PC; Pomat WS; Thornton RB; Kirkham LS
    Vaccine; 2021 Jun; 39(26):3486-3492. PubMed ID: 34024658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil.
    Fortuna LBDP; Miranda FM; Antunes IMF; Silva AB; Cabral AS; Dolores ÍM; Cardoso-Marques NT; Teixeira LM; Neves FPG
    Vaccine; 2023 May; 41(19):3111-3118. PubMed ID: 37061371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of antibiotic-resistant non-vaccine serotype pneumococci in nasopharyngeal carriage in children after the use of extended-valency pneumococcal conjugate vaccines in Korea.
    Choe YJ; Lee HJ; Lee H; Oh CE; Cho EY; Choi JH; Kang HM; Yoon IA; Jung HJ; Choi EH
    Vaccine; 2016 Sep; 34(40):4771-6. PubMed ID: 27546875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal Carriage Among Indigenous Kichwa Children From the Ecuadorian Andes After the 10-Valent Pneumococcal Vaccine Introduction.
    Regalado L D; Rivera-Olivero IA; Garcia-Bereguiain MA; Tana L; Hernandez I; Zurita J; Vidal JE; Terán E; de Waard JH
    Pediatr Infect Dis J; 2021 Nov; 40(11):e427-e433. PubMed ID: 34609109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.
    Temple B; Toan NT; Dai VTT; Bright K; Licciardi PV; Marimla RA; Nguyen CD; Uyen DY; Balloch A; Huu TN; Mulholland EK
    Lancet Infect Dis; 2019 May; 19(5):497-509. PubMed ID: 30975525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.
    Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA
    Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.